745 Atlantic Avenue
617-412-7000 or 44-117-230-2405
FDNA’s mission is to save lives and improve the quality of life of patients with rare or difficult-to-diagnose genetic syndromes. FDNA has developed the proprietary Facial Dysmorphology Novel Analysis (FDNA®) technology. This cutting-edge technology facilitates the detection of facial dysmorphic features and recognizable patterns of human malformations from facial photos.
Founders: Moti Shniberg and Lior Wolf
CEO: Dekel Gelbman
Please click here for FDNA job opportunities.